Cargando…

The Role of Genetic Data in Selecting Device-Aided Therapies in Patients With Advanced Parkinson’s Disease: A Mini-Review

Parkinson’s disease (PD) is a common neurodegenerative disease. At present, 5–10% of PD patients are found to have monogenic form of the disease. Each genetic mutation has its own unique clinical features and disease trajectory. It is unclear if the genetic background can affect the outcome of devic...

Descripción completa

Detalles Bibliográficos
Autor principal:	Chan, Germaine Hiu-Fai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226397/ https://www.ncbi.nlm.nih.gov/pubmed/35754954 http://dx.doi.org/10.3389/fnagi.2022.895430

Ejemplares similares

Recent advances in using diffusion tensor imaging to study white matter alterations in Parkinson’s disease: A mini review
por: Shih, Yao-Chia, et al.
Publicado: (2023)

Editorial: Advancing the treatment landscape in Parkinson's disease using sensor technology and data-driven modeling
por: Ramdhani, Ritesh A., et al.
Publicado: (2022)

Editorial: Genetic and molecular diversity in Parkinson's disease
por: Abdul Murad, Nor Azian, et al.
Publicado: (2022)

Editorial: Translational advances in Alzheimer's, Parkinson's, and other dementia: Molecular mechanisms, biomarkers, diagnosis, and therapies, volume II
por: Jiang, Jiehui, et al.
Publicado: (2022)

Genetic analysis of dystonia-related genes in Parkinson's disease
por: Wang, Yige, et al.
Publicado: (2023)

Editorial: Translational Advances in Alzheimer's, Parkinson's, and Other Neurodegenerative Dementias
por: Jiang, Jiehui, et al.
Publicado: (2022)

Using Auditory Characteristics to Select Hearing Aid Compression Speeds for Presbycusic Patients
por: Zhang, Yi, et al.
Publicado: (2022)

Aging Brain and Hearing: A Mini-Review
por: Uchida, Yasue, et al.
Publicado: (2022)

Safety perception in patients with advanced idiopathic Parkinson’s disease – a qualitative study
por: Pedrosa, Anna J., et al.
Publicado: (2023)

Therapies for Parkinson’s disease and the gut microbiome: evidence for bidirectional connection
por: Hey, Grace, et al.
Publicado: (2023)

Recent trends in wearable device used to detect freezing of gait and falls in people with Parkinson’s disease: A systematic review
por: Huang, Tinghuai, et al.
Publicado: (2023)

The cognitive dysfunction of claustrum on Alzheimer’s disease: A mini-review
por: Chen, Chun-Yan, et al.
Publicado: (2023)

The role of microglial autophagy in Parkinson’s disease
por: Zhu, Rui, et al.
Publicado: (2022)

Editorial: Current advances in genetic dementia and aging
por: Xu, Yuzhen, et al.
Publicado: (2022)

Mechanisms underlying TDP-43 pathology and neurodegeneration: An updated Mini-Review
por: Nilaver, Benjamin I., et al.
Publicado: (2023)

The association between stress, emotional states, and tinnitus: a mini-review
por: Patil, Jayaditya Devpal, et al.
Publicado: (2023)

Application of Evans Index in Normal Pressure Hydrocephalus Patients: A Mini Review
por: Zhou, Xi, et al.
Publicado: (2022)

Progressive Decline in Gray and White Matter Integrity in de novo Parkinson’s Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging Data
por: Taylor, Kirsten I., et al.
Publicado: (2018)

Cognitive parameters can predict change of walking performance in advanced Parkinson’s disease – Chances and limits of early rehabilitation
por: Geritz, Johanna, et al.
Publicado: (2022)

Corrigendum: CREB5 hypermethylation involved in the ganglioside GM1 therapy of Parkinson's disease
por: Wang, Rui, et al.
Publicado: (2023)

Unraveling the transcriptomic signatures of Parkinson’s disease and major depression using single-cell and bulk data
por: Christodoulou, Christiana C., et al.
Publicado: (2023)

Identifying crosstalk genetic biomarkers linking a neurodegenerative disease, Parkinson’s disease, and periodontitis using integrated bioinformatics analyses
por: Hu, Shaonan, et al.
Publicado: (2022)

Editorial: Current advances in genetic presentations of dementia and aging, volume II
por: Xu, Yuzhen, et al.
Publicado: (2023)

Potential roles of oxidative distress on neurodegeneration in Parkinson's disease with neuropsychiatric symptoms
por: Li, Dan-ning, et al.
Publicado: (2022)

Postural control of Parkinson’s disease: A visualized analysis based on Citespace knowledge graph
por: Li, Yan, et al.
Publicado: (2023)

Neural Plasticity Induced by Hearing Aid Use
por: Karawani, Hanin, et al.
Publicado: (2022)

ATP1A3 mutation in rapid-onset dystonia parkinsonism: New data and genotype-phenotype correlation analysis
por: Yu, Lihua, et al.
Publicado: (2022)

Genetically Predicted Levels of Circulating Inflammatory Cytokines and the Risk and Age at Onset of Parkinson’s Disease: A Two-Sample Mendelian Randomization Study
por: Zhao, Yating, et al.
Publicado: (2022)

Multimodal magnetic resonance imaging on brain structure and function changes in subjective cognitive decline: a mini-review
por: Yue, Jinhuan, et al.
Publicado: (2023)

Pathological Role of Natural Killer Cells in Parkinson's Disease: A Systematic Review
por: Zhang, Le, et al.
Publicado: (2022)

Technology-based therapy-response evaluation of axial motor symptoms under daily drug regimen of patients with Parkinson’s disease
por: Wu, Zhuang, et al.
Publicado: (2022)

Corrigendum: Diagnostic value of striatal (18)F-FP-DTBZ PET in Parkinson's disease
por: Liu, Xiu-Lin, et al.
Publicado: (2022)

Interactions between gut microbiota and Parkinson's disease: The role of microbiota-derived amino acid metabolism
por: Wang, Wang, et al.
Publicado: (2022)

A Roadmap for Future Parkinson's Pharmacogenomics in Asia
por: Akbar, Muhammad, et al.
Publicado: (2022)

Impact of aging on animal models of Parkinson's disease
por: Klæstrup, Ida Hyllen, et al.
Publicado: (2022)

Oculomotor impairments in de novo Parkinson’s disease
por: Zhou, Meng-Xi, et al.
Publicado: (2022)

Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
por: Wang, Zhifu, et al.
Publicado: (2023)

Precision medicine for Parkinson’s disease: The subtyping challenge
por: Frasier, Mark, et al.
Publicado: (2022)

How sleep quality affects activities of daily living in Parkinson’s disease: the mediating role of disease severity and the moderating role of cognition
por: Luo, Yajun, et al.
Publicado: (2023)

Iron chelators as a therapeutic option for Alzheimer’s disease—A mini-review
por: Schreiner, Oliver Daniel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bab6ueu7k6ufbsrt3q2i1aiit7